Journal profile · Immunology
Annual Review of Immunology
ISSN 0732-0582 · eISSN 1545-3278 · Annual Reviews Inc. · UNITED STATES · Annual
Annual Review of Immunology: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 39.81; subscription journal; community-reported acceptance: mostly invited papers; 29 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Annual Review of Immunology is published by Annual Reviews Inc. and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Immune Cell Function and Interaction, T-cell and B-cell Immunology and Immunotherapy and Immune Responses, together about 61.7% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
AIMS AND SCOPE OF JOURNAL: The Annual Review of Immunology focuses on basic immune mechanisms and molecular basis of immune diseases in humans. Topics include innate and adaptive immunity; immune cell development and differentiation; immune control of pathogens (viruses, bacteria, parasites) and cancer; and human immunodeficiency and autoimmune diseases.  
From the journal's Aims & Scope
Research area (LetPub): Immunology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Immune Cell Function and InteractionImmunology and Microbiology27.3%
- T-cell and B-cell ImmunologyImmunology and Microbiology22.6%
- Immunotherapy and Immune ResponsesImmunology and Microbiology11.8%
- Monoclonal and Polyclonal Antibodies ResearchMedicine5.4%
- Immune Response and InflammationImmunology and Microbiology3.8%
- CAR-T cell therapy researchMedicine3.3%
- Immunodeficiency and Autoimmune DisordersImmunology and Microbiology2.5%
- IL-33, ST2, and ILC PathwaysImmunology and Microbiology1.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Immunology | Zone 1 |
Top journal: yesReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Immunology | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Immunology | Zone 1 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 39.81LetPub ·
- Impact factor (publisher)
- 39.8Publisher website ·
- CiteScore 2026-06
- 56.5LetPub ·
- SJR 2026-06
- 16.07LetPub ·
- SNIP 2026-06
- 7.16LetPub ·
- h-index
- 279LetPub ·
- h-index
- 442OpenAlex ·
- i10-index
- 1,260OpenAlex ·
- 2-year mean citedness
- 32.53OpenAlex ·
- Self-citation rate
- 0.5%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 27LetPub ·
Articles by year OpenAlex count · 1,481 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 19 | 18 | 56 |
| 2025 | 29 | 28 | 632 |
| 2024 | 22 | 22 | 1,589 |
| 2023 | 28 | 27 | 3,462 |
| 2022 | 27 | 20 | 4,054 |
| 2021 | 32 | 17 | 6,061 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average acceptance (community reports)
- Mostly invited papersLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Annual Reviews Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Annual
- ISSN
- 0732-0582
- Electronic ISSN
- 1545-3278
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Annual Review of Immunology
What CAS zone is Annual Review of Immunology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Annual Review of Immunology is in Zone 1 of Medicine, and in Zone 1 of the minor category Immunology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Annual Review of Immunology?
The latest impact factor listed by LetPub is 39.81; CiteScore 56.5, h-index 442.
Which databases index Annual Review of Immunology?
According to LetPub and DOAJ records, Annual Review of Immunology is indexed in SCIE and Scopus.
Is Annual Review of Immunology open access, and what is the APC?
Annual Review of Immunology is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .